Related Experiment Video
Updated: Aug 2, 2026
07:27
How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children
Published on: August 19, 2020
Fibreoptic phototherapy for neonatal jaundice
1Department of Neonatology, Royal Children's Hospital, Flemington Road, Parkville, Victoria, Australia, 3052. millsj@cryptic.rch.unimelb.edu.au
The Cochrane Database of Systematic Reviews
|May 2, 2001
Summary
Fibreoptic phototherapy effectively lowers serum bilirubin in newborns but is less effective than conventional phototherapy. It is a safe alternative for term infants with physiological jaundice, though its impact on infant care and bonding requires further study.
Area of Science:
- Neonatal Medicine
- Pediatric Phototherapy
Background:
- Neonatal hyperbilirubinaemia is commonly treated with phototherapy.
- Fibreoptic phototherapy offers a potentially less disruptive alternative for managing elevated serum bilirubin (SBR) in newborns.
Purpose of the Study:
- To evaluate the efficacy of fibreoptic phototherapy in treating neonatal hyperbilirubinaemia.
Main Methods:
- A systematic review and meta-analysis of randomized and quasi-randomized controlled trials.
- Searches included the Cochrane Controlled Trials Register, MEDLINE, and EMBASE.
- Twenty-four studies met the inclusion criteria, evaluating fibreoptic phototherapy in various clinical scenarios.
Main Results:
- Fibreoptic phototherapy significantly reduced SBR compared to no treatment but was less effective than conventional phototherapy.
- It demonstrated equal efficacy to conventional phototherapy in preterm infants and when using two devices simultaneously.
- Combining fibreoptic and conventional phototherapy was more effective than conventional therapy alone.
Conclusions:
- Fibreoptic phototherapy is a viable option for managing neonatal hyperbilirubinaemia and appears safe for term infants with physiological jaundice.
- Evidence supporting claims of reduced interference with infant care or improved parent-child bonding with fibreoptic devices is currently lacking.
More Related Videos
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...